Block Grant U62PS001197

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $4.76 million Project Grant to The Regents of the University of California, San Francisco under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support the Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II). Awarded on September 23, 2025, with a completion date of August 31, 2030, this initiative addresses critical gaps in tuberculosis (TB) diagnostics in...

Federal Project Grant Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $743,651 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Regents of the University of California, San Francisco, effective August 1, 2025, through July 31, 2030. The project focuses on developing and validating plasma cell-free RNA (cfRNA) biomarkers for tuberculosis diagnosis and treatment monitoring. The research team will conduct diagnostic...

Federal Grant Award Summary Primary Care Training and Enhancement – Residency Training in Street Medicine Mainehealth received a $271,081 Project Grant from the Department of Health and Human Services Bureau of Health Professionals under the Primary Care Training and Enhancement (PCTE) program (CFDA 93.884), effective July 1, 2025 through June 30, 2030. The grant supports the development and delivery of specialized residency training for family medicine residents in street medicine and primary...

Federal Grant Award Summary The Research Foundation for the State University of New York received a $1,000,000 Project Grant from the Department of Health and Human Services Bureau of Health Professionals under the Primary Care Training and Enhancement (PCTE) program (CFDA 93.884), effective July 1, 2025 through June 30, 2030. The University at Buffalo Primary Care Training and Enhancement–Residency Training in Street Medicine (UBPCTE-RTSM) program establishes comprehensive street medicine...

Federal Grant Award Summary Tallahassee Memorial Healthcare, Inc. received a $999,046 Project Grant awarded July 1, 2025, through the Bureau of Health Professionals under the Primary Care Training and Enhancement (PCTE) program (CFDA 93.884). This five-year initiative, extending through June 30, 2030, enhances primary care residency training in street medicine to address healthcare access barriers for individuals experiencing homelessness in Leon County and surrounding areas. The program...

Federal Grant Award Summary The Johns Hopkins University received a $499,999 Project Grant from the Health Resources and Services Administration (HRSA) Bureau of Health Professionals under the Primary Care Training and Enhancement (PCTE) program (CFDA 93.884), effective July 1, 2025 through June 30, 2030. The award supports the development of specialized residency training in street medicine within Johns Hopkins' combined Internal Medicine-Pediatrics residency program. The program will produce...

The Department of Homelessness & Supportive Housing in San Francisco, CA was awarded a $1,029,208 Project Grant from the U.S. Department of Housing and Urban Development (HUD) under the Continuum of Care (CoC) Program (CFDA 14.267). This funding will support the department's efforts to address homelessness through a range of housing assistance and supportive services, including rapid rehousing, rental assistance, case management, homelessness prevention, and community integration services....

This $2,311,192 Continuum of Care Program (CFDA 14.267) project grant, awarded by the U.S. Department of Housing and Urban Development (HUD), will support the Department of Homelessness & Supportive Housing in San Francisco, CA to provide a range of services designed to quickly rehouse homeless individuals and families. Key services to be delivered include permanent housing, transitional housing, rapid rehousing, rental assistance, case management, job training, mental health and substance...

Federal Grant Award Summary Pace Diagnostics, Inc. received a $600,000 Project Grant from the Centers for Disease Control and Prevention (CDC) Office of the Director under the CDC Investigations and Technical Assistance program (CFDA 93.283) for the development and delivery of an ultrasensitive urine tuberculosis (TB) antigen rapid detection test. The award, effective September 30, 2025, with a completion date of March 31, 2026, supports the creation of an innovative diagnostic technology...

Federal Project Grant Summary Boston Medical Center Corporation received a $872,596 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective April 1, 2026 through March 31, 2031. The award supports investigator-initiated biomedical research examining HIV-1 (Human Immunodeficiency Virus) antibody responses and pathogenesis in people living with HIV who have concurrent tuberculosis...